Log In
BCIQ
Print this Print this
 

MIN-101 (formerly CYR-101, MT-210)

Also known as: formerly CYR101

  Manage Alerts
Collapse Summary General Information
Company Mitsubishi Tanabe Pharma Corp.
DescriptionSerotonin (5-HT2A) and sigma-2 receptor antagonist
Molecular Target Serotonin (5-HT2A) receptor ; Sigma-2 receptor
Mechanism of ActionSerotonin (5-HT2A) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationSchizophrenia
Indication DetailsTreat schizophrenia
Regulatory Designation
PartnerMinerva Neurosciences Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today